Biomarker Detection
Tools for HER2, MSI/MMR, EBV, PD-L1, VEGF, CLDN18.2 and tumor profiling.
Explore research-use products for stomach cancer biology, gastric adenocarcinoma, gastric tumor microenvironment studies, H. pylori-associated inflammation, intestinal metaplasia, dysplasia, HER2 / ERBB2, MSI / MMR, EBV-positive gastric cancer, PD-L1, VEGF, CLDN18.2, angiogenesis, invasion, metastasis, drug-response models, cell culture workflows and biomarker assay development.
Build gastric tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.
Primary antibodies for HER2, PD-L1, CLDN18.2, VEGF, E-cadherin, MUC markers, Ki-67, p53, MMPs, EMT markers and gastric tumor microenvironment studies.
View antibodiesKits and assays for cytokines, angiogenesis markers, immune checkpoints, inflammatory mediators, VEGF, MMPs and gastric tumor biology workflows.
View ELISA kitsRecombinant proteins, assay standards, positive controls, calibrators and validation tools for gastric cancer biomarker assay development.
View proteinsMolecular tools for HER2 / ERBB2, MSI/MMR, EBV, CDH1, EMT, hypoxia, cytokine signaling and gastric cancer subtype profiling.
View molecular toolsMedia, matrices, supplements, transfection reagents and model-system tools for gastric adenocarcinoma cells, spheroids, organoid-like workflows and resistance models.
View culture toolsATP, cytotoxicity, apoptosis, proliferation, migration, invasion, DNA damage, oxidative stress, angiogenesis and immune-response assay systems.
View assay toolsGastric cancer research often studies molecular subtype markers, immune biology, angiogenesis, epithelial adhesion, mucin biology and surface targets. CLDN18.2 has become an important emerging gastric / gastroesophageal adenocarcinoma biomarker in recent research and treatment-selection literature. :contentReference[oaicite:1]{index=1}
HER2 / ERBB2 is studied in gastric and gastroesophageal junction adenocarcinoma signaling, amplification and biomarker workflows.
MSI / MMR markers support research into genomic instability, immune response and gastric cancer molecular subtype classification.
EBV-positive gastric cancer is studied for methylation patterns, viral oncogenesis and immune microenvironment features.
PD-L1 is studied in gastric tumor immune escape, checkpoint biology and tumor microenvironment research.
Choose a workflow and get product groups matched to stomach tumor research needs.
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, HER2, PD-L1, CLDN18.2, VEGF, Ki-67, p53, E-cadherin, MUC markers and gastric tumor tissue controls.
Browse tissue research productsUse stomach tumor research products across inflammation biology, gastric adenocarcinoma profiling, molecular subtype analysis, immune studies and drug-response models.
Study chronic gastritis, cytokines, oxidative stress, epithelial injury and mucosal repair.
Analyze gastric precancerous states, proliferation, intestinal markers and glandular transformation.
Profile EBV, MSI, chromosomal instability, genomically stable patterns, HER2 and PD-L1.
Study CDH1, E-cadherin, cell adhesion, signet-ring features and invasive growth biology.
Measure PD-L1, cytokines, T-cell markers, macrophage markers and stromal remodeling.
Measure viability, apoptosis, DNA damage, cytotoxicity, invasion and therapy-response pathways.
Product selection should match the biological target, gastric cancer subtype, sample type, assay format and validation requirements.
Examples: HER2, MSI/MMR, EBV, PD-L1, CLDN18.2, VEGF, H. pylori inflammation, EMT or invasion.
Review whether the product supports gastric adenocarcinoma, intestinal-type, diffuse-type, EBV-positive, MSI or CIN research.
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Include positive controls, negative controls, calibrators, reference lysates, recombinant standards and reproducibility checks.
Explore research-use tools for gastric tumor biology, HER2, MSI/MMR, EBV, PD-L1, CLDN18.2, VEGF, H. pylori inflammation, intestinal metaplasia, dysplasia, immune microenvironment studies, invasion and experimental drug-response workflows.
Clear answers to common product-selection and gastric tumor workflow questions.
Stomach cancer research products are laboratory-use reagents and assay tools used to study gastric tumor biology, gastric adenocarcinoma, H. pylori inflammation, biomarkers, cell models, immune escape, invasion and drug response.
Frequently studied markers include HER2 / ERBB2, MSI/MMR, EBV, PD-L1, VEGF, CLDN18.2, E-cadherin, Ki-67, p53, MUC markers, EMT markers and inflammatory cytokines.
Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, HER2, PD-L1, CLDN18.2, VEGF, E-cadherin and proliferation markers.
No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.
Authoritative sources supporting stomach cancer biology, biomarkers and research context.